Johnson & Johnson Vision Promotes the Patient Experience at FTC Workshop
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services.
Peter Menziuso and Carol Lakkis represented Johnson & Johnson at the Federal Trade Commission’s public workshop in Washington D.C. where they emphasized the company’s obligation to eye health and patient safety.
The workshop was put on as part of the FTC’s 10-year review of the Contact Lens Rule. It provided stakeholders the opportunity to share feedback on how proposed changes can affect patient-doctor relationships and consumer access to contemporary contact lenses.
Menziuso and Lakkis emphasized the benefits of a booming contact lens marketplace that promotes patient experience and minimizes health-related risks.
“Three things are critical to ensuring a healthy eye health community – both now and in the future. First, is continuing to promote the importance of the doctor-patient relationship and regular, comprehensive eye exams. Next, is making sure patients receive the exact contact lenses as prescribed, regardless of where they choose to purchase. And lastly, we believe that contact lens wearers deserve care consistent with the high standard of care they receive in their eye doctor’s office, regardless of where or how they receive it.” – Dr. Peter Menziuso, President Johnson & Johnson Vision Care, Inc. North America